EOLS - Evolus, Inc.

Valuation of Evolus, Inc.(EOLS), Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and t

Evolus, Inc.

EOLS

NASDAQ

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

11.62 USD

0.185 (1.59%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Apr 29, 2024 10:04 AM

Share Price on Valuation Date

$11.62

Stock Beta

1.45

Shares Outstanding

61497600

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.